Brent L. Saunders, Director of ARS Pharmaceuticals SPRY, has filed 5 purchases and 1 sale on the open market. Over the past 12 months that comes to a net purchase of $252K. The latest trade was on 06/24.

BS

BS

Brent L. Saunders

Director

Company

ARS Pharmaceuticals SPRY

First filing

23/06/16

Trades

36 trades

Buys / sales

5 / 1

12-month net buying

$252K

Last trade

06/24

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Bausch & LombBLCO	Open-market buy	03/06	03/10	14,700 sh	$17.14	$251,958	+1.5%
Bausch & LombBLCO	Open-market buy	25/05/22	25/05/27	22,000 sh	$11.28	$248,160	+3.2%
ARS PharmaceuticalsSPRY	Open-market sale	25/05/20	25/05/22	120,000 sh	$14.25	$1,710,000	−100.0%
SkinHealth SystemsSKIN	Open-market buy	24/08/12	24/08/13	40,450 sh	$1.08	$43,686	+0.7%
Bausch & LombBLCO	Open-market buy	24/08/05	24/08/07	32,250 sh	$15.66	$505,035	+5.7%
SkinHealth SystemsSKIN	Open-market buy	23/08/16	23/08/17	59,380 sh	$6.10	$362,218	+1.0%